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Assisted pressure control ventilation (PCV) via a min-tracheostomy tube (MTT) was conducted to improve gas
exchange and reduce the work of breathing of lung cancer patients after surgery.
Thirty-two patients with lung cancer underwent lobectomy and were managed postoperatively by assisted PCV
via an MTT. On the basis of a simulation study using a lung model for clinical use, we set the inspiratory pressure
to 20 cmH2O and inspiratory time to 1.0 sec to produce a 450-ml supported volume via the MTT per breath. The
blood gases and respiratory rate of each patient were measured under three sets of conditions: PCV via an MTT
transtracheal oxygenation (TTO) via an MTT and a Venturi face mask with the same FiO2. After PCV via an MTT
overnight, the blood gases in the room air were measured 2.5 h after withdrawing PCV. In order to determine the
eect of PCV via an MTT on gas exchange after PCV withdrawal, 32 other age and sex-matched lung cancer
patients, who had undergone lobectomy and oxygenation via a face mask alone after surgery, were used as
historical controls.
The simulation study showed that the ventilated volume provided by assisted PCV via an MTT was about half
that provided via a conventional endotracheal tube, even in the presence of air leakage. The clinical application
showed that the ventilated volume obtained with the PCV via an MTT was significantly higher than that with
spontaneous breathing (P50.001). PCV via an MTT increased the PaO2 and reduced both the PaCO2 and
respiratory rate significantly in comparison with TTO via an MTT and a face mask (P50.001). After PCV
withdrawal the morning after surgery, the PaO2 of the PCV group was significantly higher than that of the
historical controls (P50.001). No postoperative pulmonary complications were observed in either the PCV or the
control groups, however. In addition, no complications or morbidity were seen related to either MTT insertion or
PCV via an MTT.
Assisted PVC via an MTT increased the tidal volume, improved the gas exchange, reduced the respiratory rate by
providing adequate ventilatory support and increased the PaO2, even after withdrawal following lung surgery. Even
though we did not observe any benefit of clinical outcome with PCV via an MTT in the present study, this
procedure appears to be a potentially useful respiratory management modality for patients with high risk of
postoperative pulmonary complications.
Key words: pressure control ventilation; minitracheostomy tube; positive airway pressure; postoperative pulmonary
complications.
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After lung resection, pulmonary gas exchange deteriorates
due to the loss of functional parenchyma, respiratory drive
depression by narcotics and microatelectasis due to sputum
retention during surgery. Postoperative continuous positive
airway pressure (CPAP) administered by a facial or nasalReceived 8 March 1999 and accepted in revised form 22 September
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0954-6111/00/030214+07 $35?00/0mask restores the functional residual capacity to preopera-
tive values, improves oxygenation, spares inspiratory
muscle work and prevents and treats pulmonary atelectasis
(1,2). Bilevel positive airway pressure (BiPAP System;
Respironics Inc; Murrysville, PA, U.S.A.), which combines
pressure support ventilation (PSV) and positive end-
expiratory pressure (PEEP), has been used to improve gas
exchange in patients with dierent forms of respiratory
failure (3–5) and has also been tried for preventing and
treating pulmonary atelectasis after upper abdominal and
lung surgery (6,7). However, CPAP and BiPAP require the
patient’s participation and can only be administered for a
limited time because of the oppressive sensation of the
facial or nasal mask.# 2000 HARCOURT PUBLISHERS LTD
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(MTT) has been used as an emergency life saving measure
when tracheal intubation is rendered unfeasible by total
airway obstruction. The ventilatory modes generally used in
such situations are jet ventilation, oxygen flushing or a
standard anesthesia circle system with high pressure (8).
Gregoretti et al. reported a patient with flail chest trauma
who was treated successfully using pressure control
ventilation (PCV) via an MTT (9). Since 1988, we have
used MTTs regularly to treat postoperative sputum
retention in order to prevent atelectasis and pneumonia
after lung cancer surgery. Now, we also use MTTs to
provide overnight ventilatory support after lung resection
in order to improve gas exchange and reduce the work of
breathing. We conducted a simulation study of ventilatory
support via an MTT using a lung model to determine the
optimal ventilator set-up for clinical use and present the
results of its use in patients undergoing lung surgery.
Materials and methods
SIMULATION STUDY
The airway resistance of an MTT [internal diameter (ID),
4 mm; Minitrach II, Portex Ltd., Hythe, Kent, U.K.] and
an endotracheal tube (ID, 8 mm) was examined by
measuring the airway pressures at air flow rates of 20–80
1 min71.
The lung model was the two-compartment bellows
system (Dual Adult TTL, Michigan Instruments, Grand
Rapids, MI, U.S.A.) developed by Katz et al. (10). One
compartment was connected in sequence to the test
ventilator and the other to the ventilator (‘muscle’
ventilator) used to represent the patient’s breathing (Fig. 1).
Both ventilators were Bear 1000 ventilators (Bear Medical
Systems. Inc., Riverside CA, U.S.A.) The muscle ventilator
was used to inflate one compartment, which displaced the
other compartment with a lift bar, simulating the function
of the respiratory muscles. As the other compartmentFIG. 1. Lung model using a training test lung (TTL) to
simulate spontaneous breathing.expanded, the resultant negative pressure was transmitted
to the test ventilator through the MTT. The lung model’s
air leakage adapter (2 mm in diameter) was used to simulate
clinical air leakage. An endotracheal tube (ID, 8 mm) was
used instead of the MTT in the control experiment. The
lung compliance of both compartments was set to 50 ml
cmH2O
71, the volume of the muscle ventilator to 100 ml,
the respiratory rate to 6 min71 and the air flow rate 30 l
min71. The test ventilator was set to PCV mode with the
inspiratory time fixed at 1.0 sec, respiratory rate at 0 min71,
sensitivity at 71 cmH2O and PEEP to 0 cmH2O. The
inspiratory pressure was varied between 10 and 25 cmH2O
and the alveolar pressure of the lung model and inspiratory
volume of the test ventilator were measured using a
calibration analyser (RT-200, Timester, St. Louis, MO,
U.S.A.). The ventilated volume was read from the
graduations of the lung model and the leakage volume
from the leakage adapter was calculated by subtracting the
ventilated volume from the inspired volume.
SUBJECTS
From January 1997 to January 1998, 35 lung cancer
patients underwent lobectomy. All but three who had
postoperative air leakage from the lung, had an MTT
inserted after surgery and were managed by assisted PCV
via the MTT in intensive care unit (ICU) until the next
morning. Since 1988, we have regularly used MTTs to treat
postoperative sputum retention in lung cancer patients. We
informed the patients participating in this study about the
use of an MTT for ventilatory support overnight in
addition to its use to treat postoperative sputum retention
and obtained written consent from them all. The subjects
comprised 25 men and seven women with a mean age of
63 years (range: 42–75). They were intubated with a double-
lumen tube and standard anesthesia with inhaled isoflurane,
nitrous oxide and oxygen and intravenous pancronium
bromide was administered. When the pleural space was
opened, single-lung ventilation was used. On completion of
surgery, the patients were extubated and, using a guide
wire, an MTT (ID, 4 mm) was inserted under local
anesthesia via the cricothyroid membrane. Epidural mor-
phine (3 mg 24 h71) was started when anesthesia was
started and continued for 3 days postoperatively.
In order to determine the eect of PCV via an MTT on
pulmonary gas exchange after PCV withdrawal, 32 other
lung cancer patients who had undergone lobectomy, MTT
intubation and postoperative respiratory care with oxyge-
nation via a Venturi face mask alone were used as historical
controls. They were selected consecutively from 131
patients who underwent lung cancer surgery between 1993
and 1996 to match the sexes and ages (+5 years) of those in
the PCV group (Table 1). The preoperative pulmonary
function, blood gas analysis results and sites of lobectomy
of the two groups were not significantly dierent. All the
patients underwent similar general anesthetic procedures
and epidural anesthesia with morphine and were intubated
with a double-lumen endotracheal tube to enable selective
contralateral ventilation and lobectomy to be performed.
0 cmH2O, i.e. transtracheal oxygenation (TTO) given by
oxygen flow through the ventilator (FiO2: 04), and the
same parameters were measured 30 min later ( in Fig. 2).
Then, the patients were oxygenated via a Venturi face
mask alone (oxygen flow rate: 8 l min71: FiO2: 04) with the
MTT closed and the same parameters were measured 30
min later ( in Fig. 2). The FiO2 under each set of
conditions was maintained at 0.4. Finally, the patients
underwent assisted PCV via an MTT with face mask
oxygenation again overnight and 25 h after PCV with-
drawal the next morning, the blood gases while sponta-
neously breathing room air with the MTT closed were
measured ( in Fig. 2).
TABLE 1. Patients’ profiles
Group PCV via an MTT Controls (face-mask)
Male/female 25/7 25/7
Age (years) 63+9 60+9
Preoperative pulmonary function
VC (1) 3.0+0.7 3.2+0.8
%VC 95+17 103+17
FEV1 (1) 2.2+0.6 2.4+0.6
%FEV1 74+9 78+8
Preoperative blood gas analysis
PaO2 (torr) 84+9 85+11
PaCO2 (torr) 42+3 43+2
Sites of lobectomy
RUL 11 11
RLL 9 59
RML+RLL 2 3
LUL 7 6
LLL 3 3
PCV: pressure control ventilation; MTT: minitracheostomy
tube; BGA: blood gas analysis; VC: vital capacity; FEV1:
forced expiratory volume in 1 sec; RUL: right upper lobe;
RLL: right lower lobe; RML: right middle lobe; LUL: left
upper lobe; LLL: left lower lobe.
FIG. 2. Time schedule of the study.
FIG. 3. Assisted pressure control ventilation via a
minitracheostomy tube.
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postoperative sputum retention, but not to provide post-
operative ventilatory support. The blood gases while
spontaneously breathing room air were measured the next
morning 30 min after withdrawing the face mask.
STUDY DESIGN
The time schedule of the study is shown in Fig. 2. After
entering the ICU, the patients were oxygenated via a
Venturi face mask (oxygen flow rate: 8 l min71; FiO2: 0.4;
Unimed Co., Armagh, Northern Ireland) and transtracheal
ventilation via an MTT by assisted PCV using a Bear 1000
ventilator (Fig. 3). The assisted PCV conditions were set as
follows: respiratory rate, 0 min71; pressure, 20 cmH2O;
inspiratory time, 10 sec; PEEP, 0 cmH2O; and FiO2, 04,
the conditions which provided a 450-ml supported volume
via the MTT in the simulation study. When the haemody-
namics, consciousness and pain had stabilized (23+04 h
after extubation), the volumes expired via the MTT were
read o the ventilator display and the expired volume via
the mouth was measured using a spirometer. The tidal
volume under the conditions of PCV via an MTT was
calculated from the total of the two expired volumes and
the average value of 20 breaths was determined. The
average tidal volume of 20 breaths while breathing
spontaneously with the MTT closed was measured using
a spirometer. Assisted PCV via the MTT was restarted and
the respiratory rate, blood gases, supported volume via the
MTT and haemodynamics were measured 30 min later
( in Fig. 2). The inspiratory pressure was changed toSTATISTICAL ANALYSIS
The dierences between the blood gas and respiratory rate
values under each set of respiratory conditions were
analysed for significance using the two-tailed Student’s t-
test for paired values. The dierences between the blood gas
values the morning after surgery of the PCV and control
POSTOPERATIVE RESPIRATORY MANAGEMENT OF LUNG CANCER 217groups were analysed using the two-tailed Student’s t-test.
Dierences at P5005 were considered significant. All the
values in the text and tables are means+SD.
Results
SIMULATION STUDY
The airway resistance of the endotracheal tube changed
from 16 to 49 cmH2O l71sec71 as the air flow rate was
varied from 20–80 l/min and the MTT resistance increased
from 30–98 cmH2O l
71sec71. At every flow rate tested, the
MTT resistance was about 20 times higher than that of the
endotracheal tube.
The alveolar pressure, inspired volume and ventilated
volume via the MTT without air leakage were about 50%
of those via the endotracheal tube (Table 2).The inspired
volume provided by PCV via an MTT with air leakage
was higher than that provided by PVC via an MTT without
air leakage, but the alveolar pressures and ventilated
volumes under all the conditions tested were similar. Under
the conditions of a set pressure of 20 cmH2O and an
inspiratory time of 10 sec, the ventilator provided a
ventilated volume of 450-ml via an MTT with or without
air leakage.
CLINICAL USE
Assisted PCV via an MTT responded to each patient’s
inspiration and provided adequate ventilatory support and
virtually no air leakage from the patients’ mouths occurred
during the procedure. The mean tidal volume was 571+55
ml during assisted PCV via an MTT, which was signifi-
cantly higher than that during spontaneous breathing with
the MTT closed 467–42 ml, (P50001). The mean
supported volume provided by PCV via an MTT, accordingTABLE. 2. Alveolar pressure, inspired volume and ventilated vol
and without air leakage with the inspiratory time set at 1.0 sec
Endotracheal tube
Set pressure (cmH2O) 25
Alveolar pressure (cmH2O) 25.7
Inspired volume (1) 1.19
Ventilated volume (1) 1.23
Minitracheostomy tube without air leakage
Set pressure (cmH2O) 25
Alveolar pressure (cmH2O) 12.3
Inspired volume (1) 0.52
Ventilated volume (1) 0.52
Minitracheostomy tube with air leakage
Set pressure (cmH2O) 25
Alveolar pressure (cmH2O) 11.8
Inspired volume (1) 0.77
Ventilated volume (1) 0.5
Leakage volume (1) 0.27to the ventilator’s display, was 451+18 ml, which was
similar to that provided by MTT without air leakage in the
simulation study. PCV via an MTT did not change the
heart rate, systemic blood pressure or diastolic blood
pressure, the patients’ speech was not disturbed, the
patients did not complain of discomfort during the
procedure and it did not induce pleural air leakage. Chest
X-rays one day after surgery revealed no pneumothorax or
atelectasis. There were no complications with MTT
insertion, such as surgical emphysema, haemorrhage and
misdisplacement.
The mean PaO2 distribution values [Fig. 4(a)] were
1572+245 torr for PCV via an MTT, 1293+261 torr for
TTO via an MTT and 1338+323 torr with a face mask.
PCV via an MTT resulted in a significantly higher PaO2
than TTO via an MTT or a face mask (P50001) and the
PaO2 values with the latter two procedure were not
significantly dierent.
The mean PaCO2 distribution values [Fig. 4(b)] were
401+45 torr for PCV via an MTT, 447+41 torr for TTO
via an MTT and 454+42 torr with a face mask. PCV via
an MTT resulted in a significantly lower PaCO2 than TTO
via an MTT or face mask (P50001) and the PaCO2 values
with the latter two procedures were not significantly
dierent.
The mean respiratory rate distribution values [Fig. 4(c)]
were 164+34 min71 for PCV via anMTT, 199+34 min71
for TTO via an MTT and 203+42 min71 with a face mask.
The respiratory rates with PCV via an MTT were signifi-
cantly lower than that with TTO via an MTT (P50001) or a
face mask (P50001) and the respiratory rates with the
latter two procedures were not significantly dierent.
The mean PaO2 values while breathing room air the next
morning of the groups on PCV via an MTT and
oxygenation only via a face mask were 726+88 and
659+62 torr, respectively (Fig. 5). The PaO2 of the PCV
group was significantly higher than that of the controlume via endotracheal tube and a minitracheostomy tube with
20 15 10
21.8 16.6 11.6
0.99 0.74 0.48
1.0 0.8 0.5
20 15 10
11.4 9.8 7.8
0.45 0.37 0.28
0.45 0.4 0.3
20 15 10
10.5 9.4 7.3
0.68 0.57 0.44
0.47 0.38 0.3
0.21 0.19 0.14
FIG. 4. (a) PaO2 , (b) PaO2 and (c) respiratory rate distributions under the conditions of PCV via an MTT, TTO via an
MTT, and a face mask. (For abbreviations see text.)
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PaCO2 values of the PCV and control groups were
448+30 and 463+36 torr, respectively, and were not
significantly dierent. No postoperative pulmonary com-
plications were observed in either the PCV or the control
groups, however.
Discussion
Generally, MTTs are used for sputum drainage in patients
with a restricted ability to expectorate. We use MTTsroutinely to treat sputum retention after lung cancer
surgery. MTTs have also been used for transtracheal
ventilation for emergency life saving when tracheal intuba-
tion is unfeasible. In this study, we used an MTT to provide
ventilatory support to improve gas exchange and reduce the
work of breathing in addition to treating sputum retention
after lung surgery. We used assisted PCV for the following
reasons: 1. adequate spontaneous postoperative breathing
did not require mandatory ventilation and pressure support
for spontaneous breathing was sucient; 2. although
pressure support ventilation (PSV) can respond to a
patient’s inspiration, the flow threshold that triggers
FIG. 5. PaO2 distributions of the pressure control
ventilation (PCV) and control groups the morning after
surgery.
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via an MTT is too low, resulting in prolonged inspiration
known as ‘inspiratory hang-up’; and 3. assisted PCV
responds to a patient’s inspiration in much the same way
as PSV and can set an inspiration time, resulting in regular
ventilatory support via the MTT for spontaneous breath-
ing.
The simulation study using a lung model showed that
assisted PCV via an MTT yielded an adequate ventilated
volume despite the high MTT airway resistance. Even
though the airway resistance of the MTT used was much
higher than that of a conventional endotracheal tube, the
ventilated volumes achieved with PCV via an MTT without
air leakage were maintained at about 50% of the volume
provided by an endotracheal tube. As PCV via an MTT
may be accompanied by air leakage from the mouth or nose
during inspiration when it is used clinically, we also
examined the alveolar pressure and ventilated volume using
the leak adapter of the lung model. The results showed that
PCV via an MTT with the leak adapter yielded a similar
alveolar pressure and ventilated volume as the procedure
without air leakage, because the PCV system compensated
for air leakage by increasing the air flow. Therefore, on the
basis of the results of the simulation study, we set the
inspiratory pressure to 20 cmH2O and the inspiration time
to 1.0 sec for clinical use in order to produce a 450-ml
supported volume via the MTT using a ventilator, because
this volume is adequate after lung resection. The assisted
PCV via an MTT significantly increased the ventilated
volume and reduced the respiratory rate in comparison with
spontaneous breathing. Therefore, we surmise that the
patients could inspire with less work of breathing on PCV
via an MTT than they could when breathing sponta-neously. In clinical use, PCV via an MTT yielded a mean
supported volume of 451 ml, which was similar to the value
under the conditions of an MTT without air leakage in the
simulation study. The patients showed virtually no air
leakage from their mouths during the procedure. Therefore,
we consider that PCV via an MTT under the conditions we
used (a pressure of 20 cmH2O and an inspiratory time of
1.0 sec) did not provide an excessive supported volume for
patients after lung surgery.
Ventilation with PSV has been reported to increase the
PaO2 by enlarging the alveoli and recruiting zones of
alveolar collapse, resulting in better ventilation–perfusion
matching (11–13), and PSV reduced both the PaCO2 and
respiratory rate while reducing the work of breathing and
increasing the ventilated volume (14,15). The assisted PCV
technique used in our study provided similar ventilatory
support to PSV, because it provided inspiratory flow in one
second for each spontaneous inspiration. In clinical use,
assisted PCV via an MTT increased the ventilated volume
and resulted in significantly higher PaO2 values and
significantly lower PaCO2 values and respiratory rates than
TTO via an MTT or a face mask, presumably as a result of
mechanisms similar to those with PSV described above.
Although we did not actually measure the work of
breathing, we surmise that PCV via an MTT reduced the
work of breathing in the same way as does PSV, because
gas exchange improved and the respiratory rate decreased
with PCV via an MTT.
We verified that the PaO2 2.5 h after PCV withdrawal the
morning after surgery was significantly higher than that of
the control subjects. This finding indicates that PCV via an
MTT overnight opened previously closed lung units during
the procedure and they remained open after PCV with-
drawal, i.e. it treated postoperative lung microatelectasis
resulting in better ventilation–perfusion matching.
BiPAP has been tried to prevent and treat pulmonary
atelectasis after upper abdominal and lung surgery (6,7).
PCV via an MTT, although far from completely non-
invasive, has the following advantages over BiPAP: 1.
BiPAP requires the patient’s participation and the time it
can be used for is limited because of the oppressive
sensation of the nasal mask, nasal cavity irritation due to
the air flow and eye irritation due to air leakage, whereas
PCV via an MTT can be used for long periods without
discomfort; 2. PCV via an MTT reduces the ventilatory
dead space, whereas BiPAP may increase the dead space to
tidal volume ratio (16); and 3. tracheal suction via an MTT
to remove retained sputum can be carried out easily and
also helps to prevent postoperative pulmonary atelectasis
and pneumonia. Furthermore, PCV via an MTT did not
interfere with the patients’ speech. Although complications
with MTT insertion, such as surgical emphysema, haemor-
rhage and misdisplacement, have been reported (17), they
are very rare and we have never experienced them when
using a guide wire technique. Therefore, apart from the
necessity for a mini-tracheostomy, PCV via an MTT
appears to present no particular disadvantages.
In summary, we found that assisted PCV via an MTT
provided adequate ventilatory support, improved gas
exchange both during the procedure and after its with-
220 H. NOMORI ET AL.drawal and reduced the respiratory rate without adverse
side eects following lung cancer surgery. Although we
observed no postoperative pulmonary complications in
either the PCV or control groups, we believe that this
procedure appears to be a potentially useful respiratory
management modality for patients with high risk of
postoperative pulmonary complications after lung surgery.
A prospective study on patients at high risk of post-
operative pulmonary complications should be conducted.
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